enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021)
enVVeno Medical (NVNO) posted quarterly Long-Term Deferred Tax of $14.5 million for Q4 2021, up 32.76% year-over-year from $10.9 million in Q4 2020, and up 32.76% quarter-over-quarter from $10.9 million in Q4 2020.
enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
enVVeno Medical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $14.5 million for Q4 2021.
- In Q4 2021, Long-Term Deferred Tax rose 32.76% year-over-year to $14.5 million; the TTM figure through Dec 2021 stood at $14.5 million (up 32.76% YoY), while the FY2021 annual figure was $14.5 million, up 32.76% from the prior year.
- Long-Term Deferred Tax for Q4 2021 stood at $14.5 million, up from $10.9 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $14.5 million in Q4 2021, with the low at $10.9 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | enVVeno Medical | 7.12 Mn | 7.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 14.31 Mn |
| Dec 31, 2020 | 10.71 Mn |